Pathway management for CHF patients

• US 7,155,277 B1
• Filed: 02/18/2003
• Issued: 12/26/2006
• Est. Priority Date: 02/18/2003
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Simcoe, Scott H., Kroll, Mark W., Brewer, James E.
• Primary Examiner(s): Pezzuto, Robert
• Assistant Examiner(s): LEE, YUN H
• Application Number:
  US10/370,125
• Time in Patent Office: 1,407 Days
• Field of Search: 128/903, 128/904, 128/920, 128/923, 607/2, 607 30- 32, 607 59- 60, 705/3
• US Class Current: 607/2
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61N 1/3625 External stimulators
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 70/20 relating to practices or guidelines

Abstract

An exemplary system and/or method allows for automated and/or semi-automated treatment of CHF, for example, via a pathway. Various exemplary systems and/or methods include a server and/or a client for creating, implementing and/or maintaining a CHF pathway. An exemplary client has a communication link with an implantable cardiac device for communicating one or more operational parameters to the implantable cardiac device and/or receiving information from the implantable cardiac device. Other exemplary systems and/or methods are also disclosed.

Claims

1. A method for treating CHF comprising:

creating a pathway for treating CHF using one or more analytical models;

implementing the pathway, at least in part, by communicating one or more parameters to an implantable cardiac device; and

maintaining the pathway, at least in part, by evaluating information received from the implantable cardiac device, wherein the creating includes prioritizing one or more factors related to quality of life, cost of care, or length of life.

2. The method of claim 1, wherein the creating includes receiving information from one or more databases.

3. The method of claim 1, wherein the creating includes use of at least one of quality of life, cost of care or length of life information.

4. The method of claim 1, wherein the one or more analytical models uses at least one of quality of life with respect to time, cost of care with respect to time or length of life with respect to time.

5. The method of claim 1, wherein the prioritizing includes prioritizing the one or more factors with respect to time.

6. The method of claim 1, wherein the one or more parameters comprise a parameter selected from the group consisting of a fibrillation detection interval parameter, a tachycardia detection interval parameter, a left ventricular pacing parameter, a therapy inhibition parameter, and a rate-responsive bradycardia therapy parameter.

7. The method of claim 1, wherein the one or more parameters includes a tolerance.

8. The method of claim 7, wherein the tolerance determines, at least in part, whether to intervene in the maintaining.

9. The method of claim 1, wherein the maintaining occurs automatically following the implementing.

10. The method of claim 1, wherein the maintaining includes changing or modifying the pathway.

11. The method of claim 10, wherein the changing or modifying depends, at least in part, on the receiving.

12. The method of claim 1, further comprising receiving patient-related information via a Web browser.

13. A method for treating CHF comprising:

creating a pathway for treating CHF using one or more analytical models that predict a likelihood of one or more patient outcomes for the CHF pathway;

implementing the pathway, at least in part, by communicating one or more parameters to an implantable cardiac device; and

maintaining the pathway, at least in part, by periodically evaluating information received from the implantable cardiac device to determine if the pathway as implemented by the implantable cardiac device satisfies one or more performance criteria and adjusting the pathway if the one or more cardiac performance criteria are not satisfied, wherein the creating includes prioritizing one or more factors related to quality of life, cost of care, or length of life.

14. The method of claim 13, further comprising receiving information from the implantable cardiac device.

15. The method of claim 14, wherein the periodic checking uses the received information.

16. A method for implementing a CHF treatment pathway, comprising:

inputting information regarding a patient into a CHF treatment pathway development model;

determining a CHF pathway using the CHF treatment pathway development model;

testing the CHF pathway using a patient model; and

responsive to the testing, implementing the CHF treatment pathway on the patient, wherein the determining of a CHF pathway includes prioritizing one or more factors related to quality of life, cost of care, or length of life.